PLAUR polymorphisms and lung function in UK smokers

BMC Medical Genetics

Volumn 10, Issue , 2009, Pages

  Stewart, Ceri E ^a   Hall, Ian P ^a   Parker, Stuart G ^b   Moffat, Miriam F ^c   Wardlaw, Andrew J ^d   Connolly, Martin J ^e   Ruse, Charlotte ^b   Sayers, Ian ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; UROKINASE RECEPTOR; PLAUR PROTEIN, HUMAN;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPIROMETRY; AGED; ASTHMA; CASE CONTROL STUDY; COHORT ANALYSIS; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; UNITED KINGDOM;

ADULT; AGED; ASTHMA; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GREAT BRITAIN; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 71549153176     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-10-112     Document Type: Article

References (36)

1. Sayers I, Beghe B, Holloway J, Holgate S. Genetics of Asthma: what's new?. Asthma: Critical Debates 2002, 138-168. Oxford: Blackwell Science Ltd, Johnston SHS.
2. Wood AM, Stockley RA. The genetics of chronic obstructive pulmonary disease. Respir Res 2006, 7:130. 10.1186/1465-9921-7-130, 17054776, 1626465.
3. Barton SJ, Koppelman GH, Vonk JM, Browning CA, Nolte IM, Stewart CE, Bainbridge S, Mutch S, Rose-Zerilli MJ, Postma DS. PLAUR polymorphisms are associated with asthma, PLAUR levels and lung function decline. J Allergy Clin Immunol 2009, 123:1406-1415.
4. Dear AE, Medcalf RL. The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule. Eur J Biochem 1998, 252(2):185-193. 10.1046/j.1432-1327.1998.2520185.x, 9523687.
5. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 2002, 3(12):932-943. 10.1038/nrm977, 12461559.
6. Kruithof EK. Plasminogen activator inhibitors--a review. Enzyme 1988, 40(2-3):113-121.
7. Jeffery P. Structural alterations and inflammation of bronchi in asthma. Int J Clin Pract Suppl 1998, 96:5-14.
8. Hogg J. Peripheral lung remodelling in asthma and chronic obstructive pulmonary disease. Eur Respir J 2004, 24(6):893-894. 10.1183/09031936.04.00110704, 15572526.
9. Silverman EK, Palmer LJ, Mosley JD, Barth M, Senter JM, Brown A, Drazen JM, Kwiatkowski DJ, Chapman HA, Campbell EJ. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002, 70(5):1229-1239. 10.1086/340316, 11914989, 447597.
10. Celedon JC, Lange C, Raby BA, Litonjua AA, Palmer LJ, DeMeo DL, Reilly JJ, Kwiatkowski DJ, Chapman HA, Laird N. The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet 2004, 13(15):1649-1656. 10.1093/hmg/ddh171, 15175276.
11. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007, 30(5):993-1013. 10.1183/09031936.00082507, 17978157.
12. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23(6):932-946. 10.1183/09031936.04.00014304, 15219010.
13. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
14. Soravia E, Grebe A, De Luca P, Helin K, Suh TT, Degen JL, Blasi F. A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene. Blood 1995, 86(2):624-635.
15. Smith N, Browning CA, Duroudier N, Stewart C, Peel S, Swan C, Hall IP, Sayers I. Salmeterol and cytokines modulate inositol-phosphate signalling in human airway smooth muscle cells via regulation at the receptor locus. Respir Res 2007, 8:68. 10.1186/1465-9921-8-68, 17903241, 2117012.
16. Xiao W, Hsu YP, Ishizaka A, Kirikae T, Moss RB. Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. Chest 2005, 128(4):2316-2326. 10.1378/chest.128.4.2316, 16236890.
17. Wang IM, Stepaniants S, Boie Y, Mortimer JR, Kennedy B, Elliott M, Hayashi S, Loy L, Coulter S, Cervino S. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 2008, 177(4):402-411. 10.1164/rccm.200703-390OC, 17975202.
18. Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007, 176(3):243-252. 10.1164/rccm.200606-828OC, 17431226, 1994221.
19. Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007, 12(5):634-641. 10.1111/j.1440-1843.2007.01136.x, 17875049.
20. Tkachuk V, Stepanova V, Little PJ, Bobik A. Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin Exp Pharmacol Physiol 1996, 23(9):759-765. 10.1111/j.1440-1681.1996.tb01177.x, 8911711.
21. May AE, Schmidt R, Kanse SM, Chavakis T, Stephens RW, Schomig A, Preissner KT, Neumann F-J. Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. Blood 2002, 100(10):3611-3617. 10.1182/blood-2002-03-0778, 12393744.
22. Wilson LA, Gemin A, Espiritu R, Singh G. ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element. FASEB J 2005, 19(14):2085-2087.
23. Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL, Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 154(3 Pt 1):813-816.
24. Loukides S, Bouros D, Papatheodorou G, Panagou P, Siafakas NM. The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 2002, 121(2):338-346. 10.1378/chest.121.2.338, 11834641.
25. Watabe T, Yoshida K, Shindoh M, Kaya M, Fujikawa K, Sato H, Seiki M, Ishii S, Fujinaga K. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 1998, 77(1):128-137. 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9, 9639404.
26. Nakatsuka H, Sokabe T, Yamamoto K, Sato Y, Hatakeyama K, Kamiya A, Ando J. Shear stress induces hepatocyte PAI-1 gene expression through cooperative Sp1/Ets-1 activation of transcription. Am J Physiol Gastrointest Liver Physiol 2006, 291(1):G26-34. 10.1152/ajpgi.00467.2005, 16500919.
27. Buchler P, Reber HA, Tomlinson JS, Hankinson O, Kallifatidis G, Friess H, Herr I, Hines OJ. Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer. Neoplasia (New York, NY) 2009, 11(2):196-206.
28. Lester RD, Jo M, Montel V, Takimoto S, Gonias SL. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. The Journal of cell biology 2007, 178(3):425-436. 10.1083/jcb.200701092, 17664334, 2064849.
29. Crippa MP. Urokinase-type plasminogen activator. Int J Biochem Cell Biol 2007, 39(4):690-694. 10.1016/j.biocel.2006.10.008, 17118695.
30. Kucharewicz I, Kowal K, Buczko W, Bodzenta-Lukaszyk A. The plasmin system in airway remodeling. Thromb Res 2003, 112(1-2):1-7. 10.1016/j.thromres.2003.10.011, 15013265.
31. Zhu G, Warren L, Aponte J, Gulsvik A, Bakke P, Anderson WH, Lomas DA, Silverman EK, Pillai SG. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med 2007, 176(2):167-173. 10.1164/rccm.200611-1723OC, 17446335.
32. DeMeo DL, Hersh CP, Hoffman EA, Litonjua AA, Lazarus R, Sparrow D, Benditt JO, Criner G, Make B, Martinez FJ. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med 2007, 176(1):42-48. 10.1164/rccm.200612-1797OC, 17363767, 2049064.
33. Hersh CP, Demeo DL, Lazarus R, Celedon JC, Raby BA, Benditt JO, Criner G, Make B, Martinez FJ, Scanlon PD. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173(9):977-984. 10.1164/rccm.200509-1452OC, 16456143, 2662917.
34. Stewart CE, Sayers I. Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells. BMC Molecular Biology 2009, 10:75. 10.1186/1471-2199-10-75, 19638192, 2724484.
35. Blasi F. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?. Immunol Today 1997, 18(9):415-417. 10.1016/S0167-5699(97)01121-3, 9293155.
36. Blasi F. The urokinase receptor. A cell surface, regulated chemokine. Apmis 1999, 107(1):96-101. 10.1111/j.1699-0463.1999.tb01531.x, 10190285.